Optic nerves and spinal cord are preferential targets of inflammation in NMO/SD, an astrocytopathic disease of the central nervous system (CNS) associated with the presence of pathogenic serum autoantibodies directed against AQP4 [1–3]. This evidence concerns the gene AQP4 and neuromyelitis optica.